Anika Therapeutics, Inc. (ANIK) SEC Filings — 2025
9 SEC filings for Anika Therapeutics, Inc. (ANIK) in 2025.
Filings
- Anika Narrows Losses Amid Strategic Divestitures, Revenue Dip — 10-Q · Nov 5, 2025
- Anika Narrows Q2 Loss, Revenue Up 7.7% on Strong Product Demand — 10-Q · Jul 30, 2025
- Anika Therapeutics Files 8-K on Officer/Director Changes & More — 8-K · Jun 24, 2025
- Anika Therapeutics Q1 2025 10-Q Filed — 10-Q · May 9, 2025
- Anika Therapeutics Files Definitive Proxy Statement — DEF 14A · Apr 28, 2025
- Anika Therapeutics Reports Officer and Director Changes — 8-K · Apr 10, 2025
- Anika Therapeutics Files 2024 10-K — 10-K · Mar 17, 2025
- Anika Therapeutics Files 8-K on Financials — 8-K · Mar 12, 2025
- Anika Therapeutics Completes Asset Acquisition — 8-K · Mar 11, 2025